| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 07/08/2004 | CA2509140A1 Complexes of e-2-methoxy-n-(3-{4-[3-methyl-4-(6-methyl-pyridin-3-yloxy)-phenylamino]-quinazolin-6-yl}-allyl)-acetamide, their method of production, and use |
| 07/08/2004 | CA2508657A1 Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists |
| 07/08/2004 | CA2508624A1 Novel piperidine derivatives as modulators of chemokine receptor ccr5 |
| 07/07/2004 | EP1435356A1 Quinoline derivatives as CRTH2 antagonists |
| 07/07/2004 | EP1434775A1 3,4-di-substituted maleimide compounds as cxc-chemokine receptor antagonists |
| 07/07/2004 | EP1434774A1 3-(4-substituted heterocyclyl)-pyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitors |
| 07/07/2004 | EP1434773A2 Heteroaryl substituted tetrazole modulators of metabotropic glutamate receptor-5 |
| 07/07/2004 | EP1434772A1 Compounds and methods |
| 07/07/2004 | EP1434769A2 Compounds useful as reversible inhibitors of cysteine proteases |
| 07/07/2004 | EP1434766A1 Piperidine compounds as muscarinic antagonists |
| 07/07/2004 | EP1434765A1 Substituted piperidines with selective binding to histamine h3-receptor |
| 07/07/2004 | EP1434763A2 Beta-lactamyl vasopressin v1a antagonists |
| 07/07/2004 | EP1434624A1 2-amino-6-(2,4,5-substituted-phenyl)-pyridines for use as nitric oxide synthase inhibitors |
| 07/07/2004 | EP1434585A1 Alkyne matrix metalloproteinase inhibitors |
| 07/07/2004 | EP1434580A2 Allylamides useful in the treatment of alzheimer's disease |
| 07/07/2004 | EP1434579A1 Imidazole derivatives as antiinflammatory agents |
| 07/07/2004 | EP1434577A1 Pyrrolidinone derivatives |
| 07/07/2004 | EP1434485A1 Nicotinic acid-heterocyclyl-amides and analogous pyrimidine derivatives serving as pesticides |
| 07/07/2004 | EP1242404B1 Phenoxypropanolamines, preparation and therapeutic use thereof |
| 07/07/2004 | EP1218359B1 Piperazine compounds as tachykinins antagonists |
| 07/07/2004 | CN1511157A Novel pyrrole derivatives as pharmaceutical agents |
| 07/07/2004 | CN1511153A 苯并咪唑衍生物 Benzimidazole derivatives |
| 07/07/2004 | CN1511152A N-formyl hydroxylamine compounds as PDF inhibitor |
| 07/07/2004 | CN1511151A 3-quinoline-2-(1H)-ylideneindolin-2-one derivatives |
| 07/07/2004 | CN1511150A Process for preparation of tetrasubstituted imidazole derivatives and novel crystalline structures thereof |
| 07/07/2004 | CN1511149A 2-thio-substituted imidazole derivatives and use therof in pharmaceutical industry |
| 07/07/2004 | CN1511143A Herbicidal substituted benzoylpyrazoles |
| 07/07/2004 | CN1511140A Oxime ether compound and agricultural or horticultural bactericide |
| 07/07/2004 | CN1511035A Gatifloxacin pentahydrate |
| 07/07/2004 | CN1510034A Indazole compound, preparing method thereof and medicine composition containing the same |
| 07/07/2004 | CN1510033A Synthesis of asymmetric dipyridyl substituted urea derivatives |
| 07/07/2004 | CN1156472C Benzotrizole derivative as agro-chemical |
| 07/07/2004 | CN1156470C New Substituted pyridyl keto enols |
| 07/07/2004 | CN1156452C Compound as anti-inflammatory agent |
| 07/07/2004 | CN1156446C Indenoindolone compounds, their preparation and medicinal compositions containing them |
| 07/07/2004 | CN1156445C Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using isindoline derivatives |
| 07/06/2004 | US6759554 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 07/06/2004 | US6759535 A 3-amide-methyl- or 3-urea-isoquinoline derivatives, enzyme inhibitor of protein kinase, for treating cell proliferation, cell death, inflammatory diseases, autoimmune diseases, bone disorders, infectious diseases, viral diseases |
| 07/06/2004 | US6759429 Having transforming growth factor- beta inhibitory activity and being useful as fibrosis inhibitors for organs or tissues |
| 07/06/2004 | US6759428 Indole nitriles |
| 07/06/2004 | US6759426 3-(Imidazolyl)-2-aminopropanoic acids |
| 07/06/2004 | US6759425 Benzimidazole compounds for modulating IgE and inhibiting cellular proliferation |
| 07/06/2004 | US6759421 Indoline compounds, a process for their preparation and pharmaceutical compositions containing them |
| 07/06/2004 | US6759418 6-(((2s)-2-(alkoxycabonyl)-4,4-difluoropyrrolidinyl)methyl)-1, 2, 3.4, 4a, 5, 6, 7, 8, 8a-decahydroisoquinoline-3-carboxylate, or acid derivatives, useful for treating migraine, and dural protein extravasation |
| 07/06/2004 | US6759414 Aromatic amides |
| 07/06/2004 | US6759412 For producing drugs used for therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction, stroke, thrombosis |
| 07/06/2004 | US6759411 Heterocyclic piperidines as modulators of chemokine receptor activity |
| 07/06/2004 | US6759410 Cytokine suppressive antiinflammatories |
| 07/06/2004 | US6759404 Inhibiting gamma-secretase activity; treating diseases associated with beta-amyloid production, such as alzheimer's disease |
| 07/06/2004 | CA2085201C New pyridyl derivatives, pharmaceutical compositions containing these compounds and processes for preparing them |
| 07/01/2004 | WO2004055015A1 Aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase-2 |
| 07/01/2004 | WO2004055010A2 Cyclopropyl compounds as ccr5 antagonists |
| 07/01/2004 | WO2004055007A1 3-substituted-4-pyrimidone derivatives |
| 07/01/2004 | WO2004055006A1 Novel compounds having selective inhibiting effect at gsk3 |
| 07/01/2004 | WO2004055005A1 Novel compounds having selective inhibiting effect at gsk3 |
| 07/01/2004 | WO2004055004A1 Carboxylic acid, phosphate or phosphonate substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators |
| 07/01/2004 | WO2004055003A1 2-substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators |
| 07/01/2004 | WO2004055002A1 Carbazole derivatives and their use as npy-5 antagonists |
| 07/01/2004 | WO2004055001A2 Rabeprazole calcium |
| 07/01/2004 | WO2004054987A1 Cathepsin cysteine protease inhibitors and their use |
| 07/01/2004 | WO2004054981A1 5-aminophenanthridine derivatives as npy-5 antagonists |
| 07/01/2004 | WO2004054624A1 Cytotoxins and diagnostic imaging agents comprising hsp90 ligands |
| 07/01/2004 | WO2004054585A1 4-anilino quinazoline derivatives for the treatment of abnormal cell growth |
| 07/01/2004 | WO2004054584A1 Novel quinoxalinone derivatives as bradykinin b1 antagonists |
| 07/01/2004 | WO2004054581A2 Cyclohexyl compounds as ccr5 antagonists |
| 07/01/2004 | WO2004054515A2 Thrombopoietin mimetics |
| 07/01/2004 | WO2004054507A2 Indolizine compounds |
| 07/01/2004 | WO2004054498A2 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof |
| 07/01/2004 | WO2004043928A3 N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobial agents |
| 07/01/2004 | WO2004039774A3 Mitotic kinesin inhibitors |
| 07/01/2004 | WO2004033426A3 Heteroaryl propyl-piperazines and heteroaryl propyl-piperidines serving as dopaminergic and serotoninergic agents |
| 07/01/2004 | WO2004032929A3 Dual binding site acetylcholinesterase inhibitors for the treatment of alzheimer’s disease |
| 07/01/2004 | WO2004031145A3 Lactam-containing diaminoalkyl, beta-aminoacids, alpha-aminoacids and derivatives thereof as factor xa inhibitors |
| 07/01/2004 | WO2004026306A3 Pyrazole derivatives as transforming growth factor (tgf) inhibitors |
| 07/01/2004 | WO2004022540A3 Pyridazinone and pyridone derivatives as adenosine antagonists |
| 07/01/2004 | WO2004018058A3 Compounds, compositions, and methods |
| 07/01/2004 | WO2004017911A3 Protease inhibitors |
| 07/01/2004 | WO2003093297A3 Protein kinase modulators and methods of use |
| 07/01/2004 | WO2003080577A3 Amidoacetonitrile compounds |
| 07/01/2004 | US20040127733 adrenergic blocking agents; for treatment of diabetes/obesity |
| 07/01/2004 | US20040127717 useful inhibitors of matrix metalloproteinases and/or TNF alpha -mediated diseases, including degenerative diseases and certain cancers |
| 07/01/2004 | US20040127708 antiviral activities; aids treatment |
| 07/01/2004 | US20040127707 Novel phthalazinones |
| 07/01/2004 | US20040127689 activated haptens useful for generating immunogens to HIV protease inhibitors |
| 07/01/2004 | US20040127658 Productivity catalysts and microstructure control |
| 07/01/2004 | US20040127548 thiophene derivative paraciticides |
| 07/01/2004 | US20040127544 Mannich base prodrugs of 3-(Pyrrol-2-yl-methylidene)-2-indolinone derivatives |
| 07/01/2004 | US20040127542 1-(Pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives |
| 07/01/2004 | US20040127536 Indazole Derivatives |
| 07/01/2004 | US20040127528 Metalloproteinase inhibitors |
| 07/01/2004 | US20040127527 Large conductance calcium-activated k channel opener |
| 07/01/2004 | US20040127517 For therapy of treat atherosclerosis, autoimmune diseases, multiple sclerosis), asthma, rheumatoid arthritis, fibrotic diseases, idiopathic pulmonary fibrosis, cystic fibrosis, glumerulonephritis, rheumatoid spondylitis, osteoarthritis, gout |
| 07/01/2004 | US20040127515 For therapy of hypertension, chronic obstructive pulmonary disease, organ damage, pain, diabetic nephropathy, dementia |
| 07/01/2004 | US20040127510 Arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methods |
| 07/01/2004 | US20040127507 Imidazolidine compounds |
| 07/01/2004 | US20040127504 Administering benzimidazole compound for therapy of sexual dysfunction in a mammal |
| 07/01/2004 | US20040127502 Use of pyrimidine compound galanin receptor subtype 3 (GAL3) antagonists, which may be classified as neutral antagonists, inverse agonists or allosteric modulators, to treat depressive disorders and/or anxiety |
| 07/01/2004 | US20040127501 Therapeutic agents useful for treating pain |
| 07/01/2004 | US20040127498 Heterocyclic side chain containing, n-substituted metalloprotease inhibitors |
| 07/01/2004 | US20040127497 Pyridyl substituted heterocycles useful for treating or preventing HCV infection |